{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":18,"n_cols":5,"rows_kept":18,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[3,2,3,3],[6,2,6,3],[7,2,7,3],[8,2,8,3],[11,2,11,3],[12,2,12,3],[16,2,16,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910452082503321"]
[null,null,"Titolo",null,"Developing a national registry of pharmacologic and biologic clinical trials [[electronic resource] ] : workshop report / / Committee on Clinical Trial Registries, Board on Health Sciences Policy, Institute of Medicine of the National Academies"]
[null,null,"Pubbl/distr/stampa",null,"Washington, D.C., : National Academies Press, c2006"]
[null,null,"ISBN",null,"1-280-50667-9"]
[{"$nulls":4},"9786610506675"]
[{"$nulls":4},"0-309-65577-3"]
[null,null,"Descrizione fisica",null,"1 online resource (124 p.)"]
[null,null,"Disciplina",null,"615.5072"]
[null,null,"Soggetti",null,"Clinical trials - United States"]
[{"$nulls":4},"Clinical medicine - Research"]
[{"$nulls":4},"Electronic books."]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Description based upon print version of record."]
[null,null,null,"Nota di bibliografia","Includes bibliographical references (p. 47-48)."]
[null,null,"Nota di contenuto",null,"\"\"Front Matter\"\"; \"\"Independent Report Reviewers \"\"; \"\"Foreword \"\"; \"\"Preface \"\"; \"\"Contents \"\"; \"\"List of Tables \"\"; \"\"1    Summary \"\"; \"\"2  The Need for Clinical Trial Registries  \"\"; \"\"3  Current Registry Activities \"\"; \"\"4  Content of a Clinical Trial Registry \"\"; \"\"5    Implementation Issues \"\"; \"\"6  Conclusion and Next Steps \"\"; \"\"References \"\"; \"\"APPENDIXES\"\"; \"\"A  Participants and Invited Experts  Between December 1, 2004, and June 27, 2005 \"\"; \"\"B  Workshop Agenda, Speakers, Panelists,  and Participants:  June 27, 2005 \"\""]
[{"$nulls":4},"\"\"C  Section 113 of the Food and Drug  Administration Modernization Act of 1997  and  Guidance for Industry: Information Programs  on Clinical Trials for Serious or Life- Threatening Diseases and Conditions. U.S. Department of Health and Human  Services.\"\"\"\"D  Published Journal Editorials \"\"; \"\"E  Joint Position on the  Disclosure of Clinical Trial Information via  Clinical Trial Registries and Databases\"\"; \"\"F  Illustrative Data Fields for the  Results Summary (based on ICH E3 template) \"\"; \"\"G Biographical Sketches of  Committee Members \"\""]